openPR Logo
Press release

Raynauds Disease Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies -Arena Pharmaceuticals, Camurus Pharmaceuticals

08-09-2023 01:07 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Raynauds Disease Market

Raynauds Disease Market

DelveInsight's "Raynauds Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Raynauds Disease, historical and forecasted epidemiology as well as the Raynauds Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Download Sample Report to know more @ https://www.delveinsight.com/sample-request/raynauds-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Raynauds Disease Overview
Raynaud's phenomenon is an episodic, exaggerated vascular response in which digital arteries constrict or spasm in response to cold temperatures or emotional stress. This disorder derives its name from Maurice Raynaud who described the first case in 1862. Prevalence rates in the general population range from 3-20%, with cold climates having a higher prevalence. Raynaud's phenomenon is more common in young women and in families of patients with Raynaud's phenomenon.
A typical episode of Raynaud's phenomenon is characterized by the sudden onset of sharply demarcated color changes of the fingers and/or toes in response to cold temperatures or emotional stress. These color changes include skin pallor (white) due to ischemia, followed by cyanosis (blue), with subsequent blushing from reperfusion (red). Classic triphasic color changes (white, blue, red) are seen in a minority of RP cases, with some patients experiencing biphasic or monophasic color changes. Generally, however, it is accepted that at least pallor must be present for the diagnosis.

Click here to learn more about the Raynauds Disease Market Landscape @ https://www.delveinsight.com/report-store/raynauds-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Key Highlights from Raynaud Disease Market Report
Key Companies working in Raynauds Disease Market include Arena Pharmaceuticals, Camurus, Eicos Sciences, Gesnyta Pharma AB, and many others.
Key Therapies included in the Raynauds Disease Market includes Temanogrel, CiVi 030, GS-248, CAM2043, and many others.

Raynaud Disease Treatment Market
Calcium channel blockers are the recommended first-line drug treatment for RP if lifestyle modification alone has failed. Nifedipine in slow-release form should be used to minimize debilitating vasodilatory side effects and short duration of action. Care should be taken to increase the dosage by increments to avoid side effects. If side effects are not severe, patients should be encouraged to tolerate them for two to three weeks as they may subside.

Learn more about the treatment market for Raynauds Disease @ https://www.delveinsight.com/sample-request/raynauds-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

The Report Covers the Raynauds Disease Epidemiology Segmented by:
Raynaud disease prevalent cases
Raynaud Disease type-specific cases
Raynaud disease gender-specific cases

Raynaud Disease Dug Profile and Companies Covered
Arena Pharmaceuticals
Camurus
Eicos Sciences
Gesnyta Pharma AB
And many others

Learn more about the Key Companies and Emerging Therapies in the Raynauds Disease Market
@https://www.delveinsight.com/report-store/Raynaud's-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr


Table of Contents
Key Insights
Raynauds Disease Introduction
Executive Summary of Raynauds Disease
Disease Background and Overview
Raynauds Disease Epidemiology and patient population
Raynauds Disease Emerging Therapies
Raynauds Disease Market Outlook
Raynauds Disease Market Access and Reimbursement of Therapies
Raynauds Disease Market Drivers
Raynauds Disease Market Barriers
Appendix
Raynauds Disease Report Methodology
DelveInsight Capabilities
Disclaimer

Learn about the detailed offerings of the Raynauds Disease Market Outlook report @
https://www.delveinsight.com/report-store/raynauds-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Related Reports
Raynauds Disease Epidemiology Forecast
https://www.delveinsight.com/report-store/intracerebral-hemorrhage-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Raynauds Disease Pipeline Insight
https://www.delveinsight.com/report-store/intracerebral-hemorrhage-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Trending Reports By DelveInsight:

Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market

Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market

Rhino Conjunctivitis Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market

Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market

Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market

Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market

Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market

Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market

Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market

Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market

Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market

Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market

Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market

Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market

Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market

Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market

Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market

Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market

Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market

DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Raynauds Disease Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies -Arena Pharmaceuticals, Camurus Pharmaceuticals here

News-ID: 3159718 • Views:

More Releases from DelveInsight Business Research LLP

Hypogonadism Pipeline Drugs Insights Report 2025 | DelveInsight
Hypogonadism Pipeline Drugs Insights Report 2025 | DelveInsight
DelveInsight's "Hypogonadism Pipeline Insight, 2025" report provides a detailed overview of the therapeutic landscape, spotlighting over 10 emerging pipeline candidates aimed at restoring hormonal balance with improved safety, delivery mechanisms, and efficacy profiles. The pipeline includes oral TRTs, selective estrogen receptor modulators (SERMs), kisspeptin analogs, gonadotropin-releasing hormone (GnRH) modulators, and gene therapies for rare genetic subtypes. Interested in learning more about the current treatment landscape and the key drivers
Medical Marijuana Pipeline Drugs Insights Report 2025 | DelveInsight
Medical Marijuana Pipeline Drugs Insights Report 2025 | DelveInsight
DelveInsight's, "Medical Marijuana Pipeline Insight 2025" report provides comprehensive insights about 25+ companies and 50+ pipeline drugs in Medical Marijuana pipeline landscape. It covers the Medical Marijuana pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Medical Marijuana pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Ovarian Cancer Pipeline Drugs Insights Report 2025 | DelveInsight
Ovarian Cancer Pipeline Drugs Insights Report 2025 | DelveInsight
DelveInsight's "Ovarian Cancer Pipeline Insight 2025" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Ovarian Cancer pipeline landscape. It covers the Ovarian Cancer Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Ovarian Cancer Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious about the latest updates in
Follicular Lymphoma Pipeline Drugs Insights Report 2025 | DelveInsight
Follicular Lymphoma Pipeline Drugs Insights Report 2025 | DelveInsight
DelveInsight's, "Follicular Lymphoma Pipeline Insight, 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma pipeline landscape. It covers the Follicular Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Follicular Lymphoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Request a sample and discover the

All 5 Releases


More Releases for Raynaud

Tableware Market covering sales outlook, demand forecast & up-to-date key trends …
The global tableware market is expected to reach a valuation of US$ 44.5 Bn by 2032, with sales growing at a 5.6% CAGR over the forecast period. Changing purchasing behavior influenced by the developing domestic segment and increasing urbanization will drive the sales of tableware. People in cities are progressively adopting a western lifestyle in several emerging economies, driving the tableware demand. The tableware market has grown significantly as
Iloprost Drugs Market Is Booming Worldwide 2021-2028 | Actelion Pharmaceuticals, …
Iloprost is a drug used for treating diseases such as pulmonary arterial hypertension, scleroderma, Raynaud syndrome, and other conditions where constriction in blood vessels and improper blood flow in tissues is found. The trade name of the drug is Ventavis or Ilomedine. Iloprost, which received approval by the U.S. Food and Drug Administration (FDA) in 2004 for pulmonary arterial hypertension. Request Here PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3284 Iloprost dilates the narrowed blood vessels
COVID-19 Impact on Raynaud’s Phenomenon Management Market Research, Size, Growt …
Raynauds Phenomenon Management Market is expected to grow significantly over next few years and generate considerable market for Raynauds Phenomenon Management . Market Report Expert has recently published a research report titled, “Raynauds Phenomenon Management Market Outlook and Statistics, 2020-2026". The report has been prepared by experienced and knowledgeable market analysts, researchers, market experts, and key option leaders within Raynauds Phenomenon Management market. It is a remarkable collecting conclusion and  analysis
MODERN PRINCESS LANVIN NEW LAUNCH
THE INSPIRATION With this new fragrance, Lanvin explores a new, highly contemporary vision of a woman: one who lives in mysterious ways, one who accepts the hidden, unmentionable facet of her actions, a rebellious adventurer. Free-spirited, she lives the life of a disarmingly modern princess, of one who breaks rules in general, and rules of romance in particular. Glamorous, untamed and fiercely sensual, she uses her own free will, playing with
A new exhibition space in Venice
FONDACO DELL’ARTE - To promote modern and contemporary art projects and encourage cultural development, Arte Communications manages and rents the exhibition space at Fondaco dell'Arte, a historical Venetian building founded between the sixteenth and the seventeenth century. Venice, historically linked to the maritime trade, inherited from Arabian culture the architectural model of the so-called "fondaco", importing it to the Venetian lagoon to provide storage spaces for merchants. The unique